Insider Trading & Executive Data
Start Free Trial
38 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
LightPath Technologies is a vertically integrated photonics manufacturer that designs and makes infrared and visible optical components, assemblies, modules and complete camera/subsystem solutions for defense, public safety, industrial, commercial, telecom and medical markets. Since 2020 it has moved up the value chain from precision molded aspheric lenses into higher‑value assemblies (LightPath 2.0) and full camera subsystems (LightPath 3.0), augmented by the 2023 Visimid and 2025 G5 Infrared acquisitions. FY2025 revenue was $37.2M (up 17%), with assemblies growing ~79% to become a larger, higher‑margin mix; the company operates manufacturing sites in the U.S., China and Latvia, sells direct/account‑based globally (~38% international), and leverages a proprietary BlackDiamond chalcogenide glass to reduce germanium exposure. Key operational pressures include customer concentration, acquisition integration, higher working capital (DCSI ~130 days), and financing/new debt with covenant mechanics tied to 2025 EBITDA.
Given LightPath’s small‑cap, manufacturing‑and‑acquisition growth profile, executive pay packages are likely to combine modest cash salary and bonuses with significant equity‑based long‑term incentives (options/RSUs/warrants) to conserve cash and align management with stock performance. Company disclosures highlight stock‑based compensation as a material accounting judgment and management is focused on EBITDA, backlog/bookings, margin expansion from assemblies and successful integration of acquisitions—so performance metrics in bonus and LTI plans are likely to emphasize revenue growth, backlog conversion, gross margin/EBITDA improvement, and execution milestones tied to new camera programs. The recent use of acquisition financing with covenant tests (leverage and fixed‑charge ratios) creates incentives to structure pay to prioritize short‑term cash flow/economic covenant compliance (e.g., cash flow or EBITDA hurdles) as well as multi‑year technical/R&D milestones given the capital intensity of thermal imaging development.
Insider trades at LightPath should be watched for signals around financing/acquisition events, quarterly revenue/backlog updates, and contract awards—periods when insiders may either buy to signal confidence or sell to meet liquidity needs given limited cash ($4.9M) and potential dilution from conversion mechanics on acquisition notes. Because management compensation and covenants are linked to EBITDA and cash metrics, insider activity may cluster ahead of or after covenant tests, refinancing announcements, or material integration milestones. Regulatory and operational factors—ITAR registration, DSP‑5 authorizations, defense contracting, and Section 16 reporting—mean stricter internal blackout windows and potential clearance‑related trading restrictions for certain executives; 10b5‑1 trading plans are common in this sector to minimize timing risk and comply with blackout periods.